Analytical Data
-
基因名
GPR89
- Application
-
别名
GPR89A; GPHRA; GPR89; SH120; CGI-13; UNQ192/PRO218; Golgi pH regulator A; Protein GPR89A; Putative MAPK-activating protein PM01; Putative NF-kappa-B-activating protein 90
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
B7ZAQ6
-
表达区间
1-455aa
-
氨基酸序列
MSFLIDSSIMITSQILFFGFGWLFFMRQLFKDYEIRQYVVQVIFSVTFAFSCTMFELIIFEILGVLNSSSRYFHWKMNLCVILLILVFMVPFYIGYFIVSNIRLLHKQRLLFSCLLWLTFMYFFWKLGDPFPILSPKHGILSIEQLISRVGVIGVTLMALLSGFGAVNCPYTYMSYFLRNVTDTDILALERRLLQTMDMIISKKKRMAMARRTMFQKGEVHNKPSGFWGMIKSVTTSASGSENLTLIQQEVDALEELSRQLFLETADLYATKERIEYSKTFKGKYFNFLGYFFSIYCVWKIFMATINIVFDRVGKTDPVTRGIEITVNYLGIQFDVKFWSQHISFILVGIIIVTSIRGLLITLTKFFYAISSSKSSNVIVLLLAQIMGMYFVSSVLLIRMSMPLEYRTIITEVLGELQFNFYHRWFDVIFLVSALSSILFLYLAHKQAPEKQMAP
-
分子量
52.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR89, a member of the G protein-coupled receptor (GPCR) family, has garnered attention due to its potential role in various physiological processes and diseases. Initially identified as an orphan receptor, studies have suggested that GPR89 may be involved in cellular signaling pathways that regulate immune responses, metabolism, and cell proliferation. Its expression has been noted in various tissues, implying a potential role in tissue-specific functions. Recent research has focused on the characterization of GPR89’s structure and function, as understanding its binding mechanisms and cellular interactions could unveil new therapeutic targets for conditions such as obesity, cancer, and autoimmune diseases. The reconstitution of GPR89 in various experimental systems has enabled scientists to delve into its signaling capabilities and physiological implications. As a result, the investigation of GPR89 recombinant proteins has emerged as a critical avenue to elucidate the receptor's biological functions, contributing to the growing body of knowledge regarding GPCRs and their involvement in health and disease. This research not only enhances our understanding of receptor biology but also holds promise for the development of novel therapeutic strategies targeting GPR89-related pathways.












